DLX6 and endometrial cancer: We found that lncRNA DLX6‐AS1 regulated DLX6 epigenetically via recruiting P300 to its promotor and showed that DLX6 and lncRNA DLX6‐AS1 are proved as oncogenes presenting new therapeutic targets in endometrial cancer.